Valens Shares Slightly Up On Declining Quarterly Revenue The Valens Company Inc. Benzinga · Oct 13, 2022
The Valens Company Q2 2022 Revenue Grows Slightly YoY, What About Adjusted EBITDA? The Valens Company Inc. (NASDAQ: VLNS) (TSX:VLNS) released its second quarter fiscal year 2022 financial results for the period ended May 31, 2022, revealing net revenue of CA$24.0 million ($18,22 jmillion), representing an increase of 3.5% over Q1 2022. Benzinga · Jul 14, 2022
The Valens Company Signs Exclusive Cannabis Partnership With Coldhaus Distribution The Valens Company Inc. (NASDAQ: VLNS) (TSX: VLNS) has secured an exclusive cannabis partnership with Coldhaus Distribution to provide integrated logistics solutions for Valens-branded cannabis products across Ontario, Alberta, and British Columbia. Benzinga · Jun 22, 2022
The Valens Company Launches Exclusive Cannabis Brand In Quebec, Recieves Notice From NASDAQ The Valens Company Inc. (NASDAQ: VLNS) (TSX:VLNS) a leading manufacturer of branded cannabis products, launched a Quebec-exclusive brand, Bon Jak. Benzinga · Jun 16, 2022
Harvest One Reaches Supply Agreement With Canopy Growth's Spectrum Therapeutics' Online Medical Store Harvest One Cannabis Inc. (OTCQB: HRVOF) (TSXV:HVT) strengthened its position in the cannabis-infused market through a supply agreement with Canopy Growth Corporation (NASDAQ: CGC). Benzinga · May 13, 2022
The Valens Company Secures Agreement For Green Roads Kiosks In Major Malls Across The US Green Roads, Inc. wholly-owned subsidiary of The Valens Company Inc. (NASDAQ: VLNS) (TSX:VLNS) has entered into an agreement with Signifi Solutions, Inc. to place cloud managed Green Roads smart kiosks in various premium mall locations around the U.S. Benzinga · Apr 21, 2022
Valens Company Q1 Revenue Increases 26% Sequentially To $18.5M The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS), a leading manufacturer of cannabis products, reported its first-quarter fiscal year 2022 financial results late on Wednesday. Highlights Benzinga · Apr 14, 2022
The Valens' Green Roads Donates $120K To The Arthritis Foundation, Presents Arthritis Pain Relief CBD Roll-On Green Roads, a subsidiary of The Valens Company (NASDAQ: VLNS) is an official supporting sponsor of the Arthritis Foundation after giving a $120,000 donation to support the organization's pain management initiative to advance improved quality of life for those living with chronic pain.< Benzinga · Mar 8, 2022
CBD Co. To Donate $120k To Arthritis Foundation, Launch Arthritis Pain Relief Roll-On Green Roads, a CBD wellness brand, subsidiary of The Valens Company (NASDAQ: VLNS), is now an official Supporting Sponsor of the Arthritis Foundation after giving a $120,000 donation to support the organization’s pain management initiative to advance im Benzinga · Mar 8, 2022
The Valens Company Posts 67% Higher Loss, Provides Strong 2023 Guidance With Revenue Of CA$225M The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) reported its fourth quarter and fiscal year financial results for the period ended November 30, 2021. Benzinga · Mar 1, 2022
The Valens Co. Begins Producing Cannabis-Infused Beverages At GTA Facility, Signs Manufacturing Partnership The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) announced the successful commissioning and completion of first shipments from Pommies – also known as Southern Cliff Brands - located in the Greater Toronto Area. Benzinga · Feb 10, 2022
The Valens Company Launches Two New Cannabis Brands Across Value And Premium Markets On Tuesday, cannabis manufacturer The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) confirmed the launch of Versus, an evolution of its Verse value brand. Benzinga · Jan 25, 2022